PUBLIC CONTRACT · 2021
Lercanidipina, Atorvastatina e Furosemida
- Contract value
- €232.18
- Signed on
- 17 December 2021
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10793213PUBLISHED SUBJECT
41 5211/2021 - Lercanidipina, Atorvastatina e Furosemida
Parties involved
- Place of performance
- Portugal, Faro, Faro
- NUTS region
- PT150 - Algarve
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- GENERIS - FARMACÊUTICA, S.A. · Tax ID 508107997
- Awardee
- FARMOZ · Tax ID 501505334
- Bidder
- JABA RECORDATI, SA. · Tax ID 500492867
- Bidder
- MYLAN, LDA. · Tax ID 502248793
- Bidder
- PHARMAKERN PRODUTOS FARMACEUTICOS · Tax ID 507002571
- Bidder
- SANDOZ FARMACÊUTICA, LDA. · Tax ID 506985261
- Bidder
- OVERPHARMA - PRODUTOS MEDICOS E FARM. · Tax ID 505792362
Values and timeline
- Contract price
- €232.18
- Procedure base price
- €0.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 27 June 2024
- Award date
- 17 December 2021
- Signing date
- 17 December 2021
- Performance period
- 30 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2020/1 - Medicamentos do aparelho cardiovascular
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5666169
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.